Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Increases By 28,550.0%

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 57,300 shares, a growth of 28,550.0% from the December 15th total of 200 shares. Based on an average daily trading volume, of 21,887,900 shares, the short-interest ratio is presently 0.0 days.

Enzolytics Trading Down 9.1 %

OTCMKTS ENZC opened at $0.00 on Wednesday. Enzolytics has a 52 week low of $0.00 and a 52 week high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.